Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada

Enrolling by invitation · Phase 3

Conditions studied: Chorea, Huntington

In brief

This study will evaluate long-term safety and tolerability of valbenazine in participants with chorea associated with Huntington Disease (HD) who participated in Study NBI-98854-HD3006 (NCT04400331) in Canada.

Key facts

Study ID

NCT06312189

Run by

Neurocrine Biosciences

People needed

7

Starts

2024-04-24

Expected to finish

2028-04-01

Last updated by the study team

2026-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Neurocrine Clinical Site — Vancouver, British Columbia, Canada
• Neurocrine Clinical Site — Ottawa, Ontario, Canada
• Neurocrine Clinical Site — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.